Multicenter Evaluation of the New Abbott RealTime Assays for Quantitative Detection of Human Immunodeficiency Virus Type 1 and Hepatitis C Virus RNA

ABSTRACT The analytical performances of the new Abbott RealTime hepatitis C virus (HCV) and human immunodeficiency virus type 1 viral load assays were compared at nine laboratories with different competitor assays. These included the Abbott LcX, Bayer Versant bDNA, Roche COBAS Amplicor, and Roche COBAS TaqMan assays. Two different protocols used during the testing period with and without a pre-m1000 RNA isolation spin were compared. The difference proved to be nonsignificant. A uracil-N-glycosylase (UNG) contamination control option in the HCV test for previous Roche COBAS Amplicor users was evaluated. It proved to decrease amplicon carryover by 100-fold independent of the amplicon input concentration. The protocol including UNG proved to overcome problems with false-positive negative controls. Comparison with other assays revealed only minor differences. The largest difference was observed between the Abbott HCV RealTime assay and the Roche COBAS Amplicor HCV Monitor version 2.0 assay.

[1]  T. Bourlet,et al.  Evaluation of the Roche Cobas TaqMan and Abbott RealTime Extraction-Quantification Systems for HIV-1 Subtypes , 2007, Journal of acquired immune deficiency syndromes.

[2]  D. Perugini,et al.  A comparative evaluation between real time Roche COBas TAQMAN 48 HCV and bDNA Bayer Versant HCV 3.0. , 2006, The new microbiologica.

[3]  Michael S Saag,et al.  Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society--USA panel. , 2006, Topics in HIV medicine : a publication of the International AIDS Society, USA.

[4]  V. Foulongne,et al.  Comparison of the LCx Human Immunodeficiency Virus (HIV) RNA Quantitative, RealTime HIV, and COBAS AmpliPrep-COBAS TaqMan Assays for Quantitation of HIV Type 1 RNA in Plasma , 2006, Journal of Clinical Microbiology.

[5]  R. Badaró,et al.  Performance of the automated Abbott RealTime HIV-1 assay on a genetically diverse panel of specimens from Brazil. , 2006, Journal of virological methods.

[6]  A. Caliendo,et al.  Multilaboratory Comparison of Hepatitis C Virus Viral Load Assays , 2006, Journal of Clinical Microbiology.

[7]  A. Geretti,et al.  Comparative Evaluation of the Performance of the Abbott Real-Time Human Immunodeficiency Virus Type 1 (HIV-1) Assay for Measurement of HIV-1 Plasma Viral Load following Automated Specimen Preparation , 2006, Journal of Clinical Microbiology.

[8]  B. Gärtner,et al.  Comparison of Conventional PCR with Real-Time PCR and Branched DNA-Based Assays for Hepatitis C Virus RNA Quantification and Clinical Significance for Genotypes 1 to 5 , 2006, Journal of Clinical Microbiology.

[9]  M. Beld,et al.  Clinical Performance of the New Roche Cobas® Taqman HCV Test and High Pure System for Extraction, Detection and Quantitation of HCV RNA in Plasma and Serum , 2006, Antiviral therapy.

[10]  C. Crabb.  NOTES AND QUOTES , 2004 .

[11]  V. Soriano,et al.  European guidelines for the clinical management and treatment of HIV-infected adults in Europe. , 2003, AIDS.

[12]  R. S. Ross,et al.  Quantitation of hepatitis C virus RNA by third generation branched DNA-based signal amplification assay. , 2002, Journal of virological methods.

[13]  H. Niesters,et al.  Clinical utility of viral quantification as a tool fordisease monitoring , 2001, Expert review of molecular diagnostics.

[14]  M. V. van Dooren,et al.  Single Rapid Real-Time Monitored Isothermal RNA Amplification Assay for Quantification of Human Immunodeficiency Virus Type 1 Isolates from Groups M, N, and O , 2001, Journal of Clinical Microbiology.

[15]  J. Vincelette,et al.  Multicenter Comparison of Roche COBAS AMPLICOR MONITOR Version 1.5, Organon Teknika NucliSens QT with Extractor, and Bayer Quantiplex Version 3.0 for Quantification of Human Immunodeficiency Virus Type 1 RNA in Plasma , 2001, Journal of Clinical Microbiology.

[16]  J. Vincelette,et al.  Multicenter Comparison of Roche COBAS AMPLICOR MONITOR Version 1.5, Organon Teknika NucliSens QT with Extractor, and Bayer Quantiplex Version 3.0 for Quantification of Human Immunodeficiency Virus Type 1 RNA in Plasma , 2000, Journal of Clinical Microbiology.

[17]  J. McHutchison,et al.  Prediction of response during interferon alfa 2b therapy in chronic hepatitis C patients using viral and biochemical characteristics: A comparison , 1997, Hepatology.

[18]  J. Prieto,et al.  Viremia after one month of interferon therapy predicts treatment outcome in patients with chronic hepatitis C. , 1997, Gastroenterology.

[19]  K. Livak,et al.  Real time quantitative PCR. , 1996, Genome research.

[20]  R. Dewar,et al.  Application of branched DNA signal amplification to monitor human immunodeficiency virus type 1 burden in human plasma. , 1994, The Journal of infectious diseases.

[21]  G. Davis,et al.  Significance of serum hepatitis C virus RNA levels in chronic hepatitis C , 1993, The Lancet.

[22]  M. Giacca,et al.  Absolute quantitation of viremia in human immunodeficiency virus infection by competitive reverse transcription and polymerase chain reaction , 1992, Journal of clinical microbiology.

[23]  D. van Strijp,et al.  NASBATM isothermal enzymatic in vitro nucleic acid amplification optimized for the diagnosis of HIV-1 infection , 1991 .

[24]  J. Compton,et al.  Nucleic acid sequence-based amplification , 1991, Nature.

[25]  J. Sninsky,et al.  Enzymatic gene amplification: qualitative and quantitative methods for detecting proviral DNA amplified in vitro. , 1988, The Journal of infectious diseases.

[26]  Michael S Saag,et al.  Treatment for Adult HIV Infection 2006 Recommendations of the International AIDS Society–USA Panel , 2006 .

[27]  Martin S. Hirsch,et al.  Treatment for adult HIV infection. , 2004 .

[28]  Thomas D. Schmittgen,et al.  Real-Time Quantitative PCR , 2002 .

[29]  D. van Strijp,et al.  NASBA isothermal enzymatic in vitro nucleic acid amplification optimized for the diagnosis of HIV-1 infection. , 1991, Journal of virological methods.